Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Accenture
Healthtrust
Cipla
US Department of Justice
Moodys
Express Scripts
Queensland Health
Harvard Business School

Generated: January 22, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Huperzine A

« Back to Dashboard

US Patents for Huperzine A

Glossary
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Huperzine A ➤ Sign Up Huperzine a analogs as acetylcholinesterase inhibitors Mayo Foundation for Medical Education and Research (Rochester, MN) ➤ Sign Up
Huperzine A ➤ Sign Up Method for the synthesis of huperzine A and analogs thereof and compounds useful therein University of Pittsburgh (Pittsburgh, PA) ➤ Sign Up
Huperzine A ➤ Sign Up Huperzines and analogs ➤ Sign Up
Huperzine A ➤ Sign Up Bioactive quisqualic acid analogs Regents of the University of Minnesota (Minneapolis, MN) ➤ Sign Up
Huperzine A ➤ Sign Up Method and composition for the treatment of apathy-amotivation syndrome The Mount Sinai School of Medicine of the City of New York (New York, NY) ➤ Sign Up
Huperzine A ➤ Sign Up C-10 analogs of huperzine a Mayo Foundation for Medical Education and Research (Rochester, MI) ➤ Sign Up
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Huperzine A

Glossary
Drugname Country Document Number Estimated Expiration Related US Patent
Huperzine A Australia 2002992 2011-05-01 ➤ Sign Up
Huperzine A World Intellectual Property Organization (WIPO) 9219238 2011-05-01 ➤ Sign Up
Huperzine A Austria 219061 2009-02-21 ➤ Sign Up
Huperzine A Austria 239709 2009-02-21 ➤ Sign Up
Huperzine A Austria 330943 2009-02-21 ➤ Sign Up
Huperzine A Canada 2047744 2009-02-21 ➤ Sign Up
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Teva
Federal Trade Commission
Dow
Cipla
Chinese Patent Office
QuintilesIMS
Merck
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2019 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
Major Patent Expirations 2019 - 2020
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2019, www.DrugPatentWatch.com.
Links

Follow DrugPatentWatch: